Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TP53 |
| Variant | W91Gfs*32 |
| Impact List | frameshift |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | TP53 W91Gfs*32 indicates a shift in the reading frame starting at amino acid 91 and terminating 32 residues downstream causing a premature truncation of the 393 amino acid Tp53 protein (UniProt.org). W91Gfs*32 maintains induction of apoptosis, but results in altered subcellular localization and a loss of transcriptional transactivation activity in a reporter assay (PMID: 31081129), and therefore, is predicted to lead to a loss of Tp53 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
TP53 mutant TP53 exon4 TP53 W91fs TP53 W91Gfs*32 TP53 mutant TP53 inact mut TP53 W91fs TP53 W91Gfs*32 |
| Transcript | NM_000546.6 |
| gDNA | chr17:g.7676098delA |
| cDNA | c.271delT |
| Protein | p.W91Gfs*32 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001126112.2 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001407262.1 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126114.2 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126114 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126113 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_000546.6 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001407264.1 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126112.3 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126113.3 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001407266.1 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_000546.5 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126113.2 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_000546 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126112 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001407268.1 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001126114.3 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| NM_001407270.1 | chr17:g.7676098delA | c.271delT | p.W91Gfs*32 | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|